 Robert Batey
Concepts (491)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Riboswitch | 36 | 2024 | 67 | 14.040 |
Why?
| | Nucleic Acid Conformation | 63 | 2025 | 728 | 6.500 |
Why?
| | RNA, Bacterial | 29 | 2023 | 190 | 5.930 |
Why?
| | RNA | 34 | 2025 | 921 | 5.500 |
Why?
| | Aptamers, Nucleotide | 25 | 2025 | 83 | 4.790 |
Why?
| | Ligands | 33 | 2024 | 664 | 3.280 |
Why?
| | Models, Molecular | 39 | 2025 | 1570 | 3.010 |
Why?
| | Vitamin B 12 | 7 | 2023 | 128 | 3.000 |
Why?
| | RNA Folding | 8 | 2023 | 38 | 2.870 |
Why?
| | Bacillus subtilis | 12 | 2020 | 66 | 2.840 |
Why?
| | S-Adenosylmethionine | 12 | 2017 | 54 | 2.670 |
Why?
| | Base Sequence | 40 | 2023 | 2181 | 2.570 |
Why?
| | Crystallography, X-Ray | 28 | 2025 | 476 | 2.560 |
Why?
| | Purines | 11 | 2019 | 176 | 2.550 |
Why?
| | RNA, Messenger | 19 | 2024 | 2833 | 2.430 |
Why?
| | Gene Expression Regulation, Bacterial | 11 | 2024 | 328 | 2.190 |
Why?
| | 5' Untranslated Regions | 10 | 2014 | 58 | 2.150 |
Why?
| | Binding Sites | 31 | 2025 | 1303 | 2.000 |
Why?
| | Transcription, Genetic | 11 | 2020 | 1457 | 1.670 |
Why?
| | Gene Expression Regulation | 13 | 2020 | 2607 | 1.490 |
Why?
| | Protein Binding | 18 | 2025 | 2224 | 1.340 |
Why?
| | RNA, Catalytic | 9 | 2024 | 187 | 1.330 |
Why?
| | Bacterial Proteins | 9 | 2020 | 879 | 1.320 |
Why?
| | Adenine | 7 | 2020 | 271 | 1.230 |
Why?
| | Molecular Sequence Data | 25 | 2015 | 2900 | 1.200 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 6 | 2007 | 19 | 1.150 |
Why?
| | Fluorescent Dyes | 3 | 2025 | 321 | 1.100 |
Why?
| | Biosensing Techniques | 2 | 2020 | 129 | 1.070 |
Why?
| | Flavin Mononucleotide | 2 | 2018 | 7 | 0.960 |
Why?
| | rhoB GTP-Binding Protein | 1 | 2025 | 4 | 0.960 |
Why?
| | Rhodamines | 1 | 2025 | 20 | 0.950 |
Why?
| | Deoxyguanosine | 2 | 2019 | 25 | 0.940 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein U | 2 | 2024 | 7 | 0.920 |
Why?
| | Bacteria | 5 | 2024 | 858 | 0.910 |
Why?
| | Tetrahydrofolates | 3 | 2015 | 18 | 0.910 |
Why?
| | Genetic Engineering | 3 | 2014 | 93 | 0.890 |
Why?
| | Escherichia coli | 10 | 2020 | 815 | 0.890 |
Why?
| | Biochemical Phenomena | 1 | 2023 | 10 | 0.820 |
Why?
| | Introns | 4 | 2014 | 258 | 0.810 |
Why?
| | Guanine | 6 | 2011 | 79 | 0.810 |
Why?
| | HMGB Proteins | 1 | 2023 | 18 | 0.800 |
Why?
| | Signal Recognition Particle | 6 | 2007 | 9 | 0.790 |
Why?
| | RNA-Binding Proteins | 7 | 2025 | 422 | 0.770 |
Why?
| | CRISPR-Cas Systems | 2 | 2020 | 125 | 0.750 |
Why?
| | Base Pairing | 12 | 2020 | 64 | 0.740 |
Why?
| | Anti-Infective Agents | 1 | 2024 | 255 | 0.700 |
Why?
| | Models, Genetic | 3 | 2020 | 600 | 0.700 |
Why?
| | Escherichia coli K12 | 1 | 2020 | 7 | 0.700 |
Why?
| | CRISPR-Associated Proteins | 1 | 2020 | 1 | 0.690 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 16 | 0.690 |
Why?
| | Enzyme Assays | 1 | 2020 | 24 | 0.680 |
Why?
| | Ribosomal Proteins | 6 | 2006 | 93 | 0.670 |
Why?
| | Magnesium | 8 | 2015 | 156 | 0.670 |
Why?
| | Chromatography, Affinity | 3 | 2009 | 88 | 0.660 |
Why?
| | Protein Biosynthesis | 3 | 2016 | 433 | 0.660 |
Why?
| | Lysine | 3 | 2012 | 294 | 0.650 |
Why?
| | Endodeoxyribonucleases | 1 | 2020 | 72 | 0.650 |
Why?
| | Thermodynamics | 12 | 2014 | 407 | 0.640 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 62 | 0.630 |
Why?
| | Gene Editing | 1 | 2020 | 80 | 0.610 |
Why?
| | RNA, Long Noncoding | 4 | 2022 | 181 | 0.580 |
Why?
| | Quinoxalines | 1 | 2018 | 66 | 0.570 |
Why?
| | Crystallization | 7 | 2019 | 143 | 0.550 |
Why?
| | Archaeal Proteins | 2 | 2009 | 50 | 0.550 |
Why?
| | Drugs, Chinese Herbal | 4 | 2017 | 21 | 0.550 |
Why?
| | Dihydroxyphenylalanine | 1 | 2017 | 9 | 0.540 |
Why?
| | 5-Hydroxytryptophan | 1 | 2017 | 21 | 0.530 |
Why?
| | Cobamides | 1 | 2017 | 20 | 0.530 |
Why?
| | Synthetic Biology | 2 | 2014 | 11 | 0.520 |
Why?
| | Receptors, Glucocorticoid | 3 | 2023 | 155 | 0.510 |
Why?
| | Ribosomes | 3 | 2006 | 186 | 0.510 |
Why?
| | Cyanobacteria | 1 | 2017 | 56 | 0.500 |
Why?
| | Kinetics | 9 | 2017 | 1670 | 0.500 |
Why?
| | Coenzymes | 1 | 2016 | 19 | 0.500 |
Why?
| | Small Molecule Libraries | 1 | 2017 | 94 | 0.500 |
Why?
| | Mutation | 9 | 2017 | 3958 | 0.490 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 452 | 0.490 |
Why?
| | Calorimetry | 3 | 2012 | 70 | 0.480 |
Why?
| | X-Ray Diffraction | 1 | 2016 | 104 | 0.480 |
Why?
| | Conserved Sequence | 8 | 2017 | 239 | 0.480 |
Why?
| | DNA | 7 | 2025 | 1459 | 0.460 |
Why?
| | Chemical Fractionation | 1 | 2014 | 26 | 0.440 |
Why?
| | Folic Acid Antagonists | 1 | 2014 | 9 | 0.430 |
Why?
| | Thermotoga maritima | 3 | 2009 | 12 | 0.430 |
Why?
| | S-Adenosylhomocysteine | 2 | 2010 | 24 | 0.420 |
Why?
| | Ribonucleotides | 5 | 2017 | 26 | 0.410 |
Why?
| | Purine Nucleotides | 1 | 2013 | 12 | 0.410 |
Why?
| | Anti-Bacterial Agents | 3 | 2024 | 1809 | 0.390 |
Why?
| | Static Electricity | 5 | 2020 | 118 | 0.390 |
Why?
| | Fluorescence | 3 | 2025 | 160 | 0.370 |
Why?
| | Streptococcus mutans | 1 | 2011 | 8 | 0.370 |
Why?
| | Ribonucleoproteins | 3 | 2020 | 105 | 0.360 |
Why?
| | Substrate Specificity | 5 | 2018 | 372 | 0.360 |
Why?
| | RNA, Ribosomal | 3 | 2003 | 168 | 0.360 |
Why?
| | Intrinsically Disordered Proteins | 2 | 2024 | 34 | 0.350 |
Why?
| | RNA, Ribosomal, 16S | 4 | 1999 | 549 | 0.340 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 305 | 0.340 |
Why?
| | RNA, Archaeal | 2 | 2009 | 16 | 0.340 |
Why?
| | Mouse Embryonic Stem Cells | 2 | 2020 | 30 | 0.330 |
Why?
| | DNA-Binding Proteins | 4 | 2023 | 1502 | 0.320 |
Why?
| | Pyrococcus horikoshii | 1 | 2009 | 4 | 0.310 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2009 | 24 | 0.310 |
Why?
| | Molecular Structure | 4 | 2018 | 489 | 0.310 |
Why?
| | Transcription Factors | 5 | 2023 | 1719 | 0.300 |
Why?
| | Geobacillus stearothermophilus | 3 | 1998 | 12 | 0.300 |
Why?
| | Models, Chemical | 3 | 2008 | 263 | 0.300 |
Why?
| | Ethanol | 5 | 2000 | 608 | 0.290 |
Why?
| | Protein Structure, Secondary | 5 | 2011 | 374 | 0.290 |
Why?
| | Fructose | 4 | 2016 | 112 | 0.290 |
Why?
| | Genes, Reporter | 2 | 2020 | 269 | 0.290 |
Why?
| | Proteobacteria | 1 | 2008 | 15 | 0.290 |
Why?
| | Gene Expression | 5 | 2014 | 1502 | 0.290 |
Why?
| | Animals | 28 | 2024 | 36940 | 0.280 |
Why?
| | Hydrogen Bonding | 5 | 2012 | 163 | 0.280 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2024 | 86 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2000 | 1242 | 0.270 |
Why?
| | Liver | 6 | 2015 | 1943 | 0.270 |
Why?
| | Genes, Switch | 1 | 2006 | 6 | 0.270 |
Why?
| | Ribonucleoproteins, Small Nucleolar | 1 | 2006 | 4 | 0.260 |
Why?
| | Protein Domains | 4 | 2025 | 289 | 0.260 |
Why?
| | RNA, Small Nucleolar | 1 | 2006 | 9 | 0.260 |
Why?
| | Hepatitis B virus | 2 | 2025 | 40 | 0.260 |
Why?
| | Thermoanaerobacter | 1 | 2006 | 1 | 0.260 |
Why?
| | Pyrimidines | 2 | 2006 | 470 | 0.250 |
Why?
| | SELEX Aptamer Technique | 1 | 2005 | 15 | 0.240 |
Why?
| | Methyltransferases | 1 | 2006 | 78 | 0.240 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2006 | 92 | 0.240 |
Why?
| | Protein Structure, Tertiary | 6 | 2009 | 861 | 0.240 |
Why?
| | Cobalt | 3 | 2016 | 52 | 0.240 |
Why?
| | Isotope Labeling | 2 | 1996 | 81 | 0.240 |
Why?
| | Hepatitis B, Chronic | 1 | 2025 | 23 | 0.240 |
Why?
| | Telomerase | 1 | 2008 | 250 | 0.230 |
Why?
| | Mutagenesis | 2 | 2020 | 179 | 0.230 |
Why?
| | Binding, Competitive | 3 | 2020 | 202 | 0.230 |
Why?
| | GATA1 Transcription Factor | 1 | 2025 | 18 | 0.230 |
Why?
| | Amino Acid Motifs | 2 | 2024 | 225 | 0.230 |
Why?
| | Magnetic Resonance Spectroscopy | 5 | 2004 | 611 | 0.230 |
Why?
| | Hypoxanthine | 1 | 2004 | 11 | 0.230 |
Why?
| | RNA-Binding Motifs | 1 | 2024 | 2 | 0.230 |
Why?
| | Fluorescence Polarization | 1 | 2024 | 37 | 0.220 |
Why?
| | Dexamethasone | 2 | 2023 | 368 | 0.220 |
Why?
| | Structure-Activity Relationship | 3 | 2018 | 570 | 0.210 |
Why?
| | Alcohol Dehydrogenase | 2 | 1994 | 15 | 0.210 |
Why?
| | X Chromosome Inactivation | 2 | 2020 | 25 | 0.210 |
Why?
| | Inappropriate Prescribing | 1 | 2024 | 55 | 0.210 |
Why?
| | Phylogeny | 4 | 2014 | 904 | 0.200 |
Why?
| | Escherichia coli Proteins | 3 | 2007 | 200 | 0.200 |
Why?
| | RNA, Viral | 2 | 2020 | 656 | 0.200 |
Why?
| | Cations, Monovalent | 1 | 2002 | 6 | 0.200 |
Why?
| | RNA, Protozoan | 2 | 2004 | 60 | 0.200 |
Why?
| | Fatty Liver | 2 | 2015 | 243 | 0.200 |
Why?
| | Cations, Divalent | 1 | 2002 | 52 | 0.200 |
Why?
| | Leucovorin | 2 | 2014 | 81 | 0.200 |
Why?
| | Iridium | 2 | 2016 | 7 | 0.190 |
Why?
| | Sequence Deletion | 2 | 2020 | 183 | 0.190 |
Why?
| | Metals | 1 | 2002 | 136 | 0.180 |
Why?
| | Estrogen Receptor alpha | 1 | 2022 | 145 | 0.180 |
Why?
| | Sheep | 1 | 2024 | 856 | 0.180 |
Why?
| | Cations | 3 | 2016 | 84 | 0.170 |
Why?
| | Leptotrichia | 1 | 2020 | 1 | 0.170 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 5 | 0.170 |
Why?
| | Molecular Conformation | 3 | 2014 | 145 | 0.170 |
Why?
| | Terminator Regions, Genetic | 2 | 2011 | 12 | 0.170 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2000 | 93 | 0.170 |
Why?
| | Rats, Wistar | 8 | 2000 | 455 | 0.170 |
Why?
| | Hepatitis, Animal | 1 | 2000 | 2 | 0.170 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 35 | 0.170 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1353 | 0.170 |
Why?
| | X Chromosome | 1 | 2020 | 53 | 0.170 |
Why?
| | Rifampin | 1 | 2020 | 84 | 0.160 |
Why?
| | Helicobacter pylori | 4 | 2001 | 42 | 0.160 |
Why?
| | Computational Biology | 1 | 2024 | 644 | 0.160 |
Why?
| | Theophylline | 1 | 2020 | 67 | 0.160 |
Why?
| | Gram-Negative Aerobic Bacteria | 2 | 1996 | 5 | 0.160 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 31 | 0.160 |
Why?
| | Endogenous Retroviruses | 1 | 2020 | 37 | 0.160 |
Why?
| | Liver Cirrhosis, Alcoholic | 2 | 1998 | 17 | 0.160 |
Why?
| | Nitrogen Isotopes | 2 | 1996 | 72 | 0.150 |
Why?
| | Point Mutation | 2 | 2011 | 235 | 0.150 |
Why?
| | Aminoimidazole Carboxamide | 2 | 2017 | 12 | 0.150 |
Why?
| | Humans | 28 | 2025 | 137585 | 0.150 |
Why?
| | Evolution, Molecular | 3 | 2014 | 493 | 0.150 |
Why?
| | Cloning, Molecular | 1 | 2020 | 534 | 0.150 |
Why?
| | Rats | 11 | 2016 | 5647 | 0.150 |
Why?
| | Carbon Isotopes | 2 | 1996 | 144 | 0.150 |
Why?
| | Models, Biological | 4 | 2017 | 1783 | 0.140 |
Why?
| | Tetrahymena thermophila | 3 | 2004 | 65 | 0.140 |
Why?
| | Genes, Bacterial | 3 | 2009 | 164 | 0.140 |
Why?
| | 2-Aminopurine | 2 | 2009 | 9 | 0.140 |
Why?
| | Polymerase Chain Reaction | 4 | 2009 | 1062 | 0.140 |
Why?
| | Drug Design | 1 | 2018 | 167 | 0.140 |
Why?
| | Insulin Resistance | 2 | 2016 | 1208 | 0.140 |
Why?
| | Hyperprolactinemia | 1 | 2017 | 5 | 0.140 |
Why?
| | Aquatic Organisms | 1 | 2017 | 10 | 0.140 |
Why?
| | Monoterpenes | 1 | 2017 | 16 | 0.140 |
Why?
| | Flavanones | 1 | 2017 | 7 | 0.140 |
Why?
| | Endotoxemia | 1 | 1998 | 86 | 0.130 |
Why?
| | Transcriptome | 1 | 2023 | 971 | 0.130 |
Why?
| | Prolactin | 1 | 2017 | 96 | 0.130 |
Why?
| | Glucosides | 1 | 2017 | 44 | 0.130 |
Why?
| | Microscopy, Fluorescence | 1 | 2018 | 402 | 0.130 |
Why?
| | Glucose Transporter Type 4 | 1 | 2016 | 40 | 0.130 |
Why?
| | T-Lymphocytes | 6 | 2001 | 1996 | 0.130 |
Why?
| | Sarcolemma | 1 | 2016 | 43 | 0.130 |
Why?
| | Temperature | 3 | 2008 | 679 | 0.130 |
Why?
| | Deuterium | 1 | 1996 | 99 | 0.120 |
Why?
| | Affinity Labels | 2 | 2007 | 26 | 0.120 |
Why?
| | Salts | 1 | 2016 | 37 | 0.120 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 79 | 0.120 |
Why?
| | Xanthones | 1 | 2015 | 6 | 0.120 |
Why?
| | Species Specificity | 1 | 2017 | 585 | 0.120 |
Why?
| | CD36 Antigens | 1 | 2015 | 36 | 0.120 |
Why?
| | Nucleotides | 1 | 1996 | 125 | 0.120 |
Why?
| | MicroRNAs | 1 | 2022 | 692 | 0.120 |
Why?
| | Diacylglycerol O-Acyltransferase | 1 | 2015 | 5 | 0.120 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2009 | 560 | 0.120 |
Why?
| | Genetic Variation | 1 | 2020 | 991 | 0.120 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2000 | 1091 | 0.120 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2015 | 57 | 0.120 |
Why?
| | Viral Proteins | 3 | 2009 | 342 | 0.120 |
Why?
| | Gastrostomy | 1 | 1996 | 117 | 0.120 |
Why?
| | Protein Engineering | 1 | 2016 | 97 | 0.110 |
Why?
| | Monocytes | 1 | 1998 | 563 | 0.110 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2014 | 155 | 0.110 |
Why?
| | Interleukin-1 | 2 | 1998 | 965 | 0.110 |
Why?
| | Hydroxocobalamin | 1 | 2014 | 26 | 0.110 |
Why?
| | Protein Conformation | 3 | 2004 | 934 | 0.110 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 1995 | 137 | 0.110 |
Why?
| | Transcription Termination, Genetic | 1 | 2014 | 19 | 0.100 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 114 | 0.100 |
Why?
| | Plasmids | 2 | 2018 | 363 | 0.100 |
Why?
| | RNA Stability | 1 | 2014 | 117 | 0.100 |
Why?
| | RNA, Transfer | 1 | 2014 | 138 | 0.100 |
Why?
| | Concanavalin A | 4 | 2000 | 76 | 0.100 |
Why?
| | Hepatitis B | 1 | 1993 | 70 | 0.100 |
Why?
| | HIV Long Terminal Repeat | 1 | 1992 | 11 | 0.100 |
Why?
| | Cytoplasm | 1 | 1993 | 274 | 0.100 |
Why?
| | Methotrexate | 1 | 2014 | 260 | 0.100 |
Why?
| | Cytoskeleton | 1 | 1993 | 191 | 0.090 |
Why?
| | Dietary Carbohydrates | 1 | 1993 | 155 | 0.090 |
Why?
| | Guanosine Triphosphate | 2 | 2004 | 91 | 0.090 |
Why?
| | Metabolic Syndrome | 1 | 2015 | 354 | 0.090 |
Why?
| | Operator Regions, Genetic | 1 | 1991 | 7 | 0.090 |
Why?
| | Fusobacterium nucleatum | 1 | 2011 | 4 | 0.090 |
Why?
| | Interleukin-6 | 4 | 2000 | 778 | 0.090 |
Why?
| | Potassium Chloride | 1 | 1991 | 38 | 0.090 |
Why?
| | Drug Discovery | 1 | 2012 | 142 | 0.090 |
Why?
| | Amino Acid Sequence | 2 | 2009 | 2139 | 0.090 |
Why?
| | Mice | 5 | 2020 | 17787 | 0.090 |
Why?
| | Potassium | 2 | 2002 | 147 | 0.090 |
Why?
| | Hepatitis B Surface Antigens | 2 | 2025 | 24 | 0.090 |
Why?
| | Bacteriophage lambda | 1 | 1991 | 88 | 0.090 |
Why?
| | Crystallography | 1 | 2010 | 28 | 0.080 |
Why?
| | Scattering, Small Angle | 1 | 2010 | 26 | 0.080 |
Why?
| | Alcohol Drinking | 2 | 1995 | 828 | 0.080 |
Why?
| | Duodenum | 3 | 1996 | 78 | 0.080 |
Why?
| | Folic Acid | 1 | 2011 | 186 | 0.080 |
Why?
| | Adenosine | 2 | 2009 | 225 | 0.080 |
Why?
| | Replication Protein A | 1 | 2009 | 13 | 0.080 |
Why?
| | Clostridium botulinum | 1 | 2009 | 4 | 0.080 |
Why?
| | Central Nervous System Depressants | 2 | 2000 | 85 | 0.080 |
Why?
| | Gastritis | 2 | 2000 | 108 | 0.080 |
Why?
| | DNA, Viral | 1 | 1991 | 364 | 0.080 |
Why?
| | Titrimetry | 1 | 2009 | 12 | 0.080 |
Why?
| | Nucleic Acid Denaturation | 1 | 2009 | 32 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 345 | 0.080 |
Why?
| | Muscle, Skeletal | 2 | 2016 | 1724 | 0.070 |
Why?
| | Open Reading Frames | 1 | 2009 | 123 | 0.070 |
Why?
| | Glucocorticoids | 2 | 2023 | 594 | 0.070 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2009 | 57 | 0.070 |
Why?
| | 3' Untranslated Regions | 1 | 2009 | 145 | 0.070 |
Why?
| | DNA, Bacterial | 2 | 2008 | 337 | 0.070 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2009 | 78 | 0.070 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 109 | 0.070 |
Why?
| | Female | 22 | 2025 | 73304 | 0.070 |
Why?
| | Sequence Alignment | 1 | 2009 | 343 | 0.070 |
Why?
| | ortho-Aminobenzoates | 1 | 2008 | 10 | 0.070 |
Why?
| | Lipopolysaccharides | 4 | 2000 | 886 | 0.070 |
Why?
| | Exons | 1 | 2009 | 355 | 0.070 |
Why?
| | Anhydrides | 1 | 2008 | 18 | 0.070 |
Why?
| | Telomere-Binding Proteins | 1 | 2009 | 122 | 0.070 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 399 | 0.070 |
Why?
| | Repressor Proteins | 1 | 1991 | 427 | 0.070 |
Why?
| | Male | 12 | 2025 | 67762 | 0.070 |
Why?
| | Nucleic Acids | 1 | 2008 | 71 | 0.070 |
Why?
| | History, 21st Century | 1 | 2008 | 213 | 0.070 |
Why?
| | Base Pair Mismatch | 1 | 2006 | 11 | 0.070 |
Why?
| | Azoarcus | 1 | 2006 | 1 | 0.060 |
Why?
| | History, 20th Century | 1 | 2008 | 325 | 0.060 |
Why?
| | Telomere | 1 | 2009 | 280 | 0.060 |
Why?
| | Interleukin-2 | 2 | 2001 | 455 | 0.060 |
Why?
| | Helicobacter Infections | 3 | 2001 | 32 | 0.060 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1291 | 0.060 |
Why?
| | Thiamine Pyrophosphate | 1 | 2006 | 3 | 0.060 |
Why?
| | Sulfur | 1 | 2006 | 58 | 0.060 |
Why?
| | Methylation | 1 | 2006 | 230 | 0.060 |
Why?
| | Alternative Splicing | 1 | 2008 | 229 | 0.060 |
Why?
| | Northern Territory | 1 | 2025 | 3 | 0.060 |
Why?
| | Hepatitis B e Antigens | 1 | 2025 | 4 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2009 | 405 | 0.060 |
Why?
| | Cell Cycle Proteins | 1 | 2009 | 617 | 0.060 |
Why?
| | Methionine | 1 | 2006 | 160 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2018 | 730 | 0.060 |
Why?
| | Alanine Transaminase | 3 | 2000 | 157 | 0.060 |
Why?
| | Operon | 1 | 2004 | 64 | 0.060 |
Why?
| | Time Factors | 3 | 2009 | 6828 | 0.060 |
Why?
| | Methanococcus | 1 | 2004 | 9 | 0.060 |
Why?
| | Microscopy, Electron | 2 | 1995 | 443 | 0.050 |
Why?
| | Lymphocyte Activation | 2 | 1998 | 1142 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2004 | 162 | 0.050 |
Why?
| | Cesium | 1 | 2002 | 20 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2025 | 316 | 0.050 |
Why?
| | Energy Transfer | 1 | 2002 | 46 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2014 | 177 | 0.050 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 220 | 0.050 |
Why?
| | Enterocytes | 1 | 2001 | 16 | 0.050 |
Why?
| | Interferon-gamma | 3 | 2001 | 789 | 0.050 |
Why?
| | Ferritins | 1 | 2021 | 64 | 0.050 |
Why?
| | Antigens, Bacterial | 2 | 2000 | 127 | 0.050 |
Why?
| | Cell Membrane Permeability | 1 | 2001 | 78 | 0.050 |
Why?
| | Body Weight | 2 | 2016 | 985 | 0.040 |
Why?
| | Ferric Compounds | 1 | 2021 | 56 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2023 | 378 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 852 | 0.040 |
Why?
| | RNA, Untranslated | 1 | 2022 | 124 | 0.040 |
Why?
| | Endopeptidases | 1 | 2001 | 90 | 0.040 |
Why?
| | RNA Splicing | 1 | 2022 | 269 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 144 | 0.040 |
Why?
| | Australia | 1 | 2021 | 315 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2017 | 2486 | 0.040 |
Why?
| | Dosage Compensation, Genetic | 1 | 2020 | 9 | 0.040 |
Why?
| | Transformation, Bacterial | 1 | 2000 | 8 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1916 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3412 | 0.040 |
Why?
| | Hepatitis, Alcoholic | 1 | 1999 | 13 | 0.040 |
Why?
| | Iron | 1 | 2021 | 313 | 0.040 |
Why?
| | Stomach Neoplasms | 1 | 2001 | 122 | 0.040 |
Why?
| | Antiviral Agents | 1 | 2025 | 744 | 0.040 |
Why?
| | Chromatin | 1 | 2023 | 519 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5472 | 0.040 |
Why?
| | Middle Aged | 9 | 2025 | 33479 | 0.040 |
Why?
| | RNA, Small Nuclear | 1 | 2018 | 37 | 0.040 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 1998 | 11 | 0.040 |
Why?
| | Color | 1 | 2018 | 76 | 0.040 |
Why?
| | Kupffer Cells | 1 | 1998 | 50 | 0.040 |
Why?
| | Tetrahymena | 1 | 1998 | 157 | 0.030 |
Why?
| | Renal Dialysis | 1 | 2021 | 435 | 0.030 |
Why?
| | RNA-Binding Protein FUS | 1 | 2017 | 13 | 0.030 |
Why?
| | Disease Progression | 1 | 2025 | 2757 | 0.030 |
Why?
| | Prolactinoma | 1 | 2017 | 13 | 0.030 |
Why?
| | G-Quadruplexes | 1 | 2017 | 19 | 0.030 |
Why?
| | Metoclopramide | 1 | 2017 | 19 | 0.030 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2017 | 50 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2020 | 620 | 0.030 |
Why?
| | Dinucleoside Phosphates | 1 | 2017 | 27 | 0.030 |
Why?
| | Cell Line | 2 | 2020 | 2847 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 364 | 0.030 |
Why?
| | Diethyl Pyrocarbonate | 1 | 1996 | 2 | 0.030 |
Why?
| | Ethylnitrosourea | 1 | 1996 | 10 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 390 | 0.030 |
Why?
| | Gastroscopy | 1 | 1996 | 19 | 0.030 |
Why?
| | Thionucleotides | 1 | 1996 | 35 | 0.030 |
Why?
| | Protein Folding | 1 | 1998 | 280 | 0.030 |
Why?
| | HeLa Cells | 1 | 2018 | 636 | 0.030 |
Why?
| | Oligoribonucleotides | 1 | 1996 | 52 | 0.030 |
Why?
| | Iodine | 1 | 1996 | 27 | 0.030 |
Why?
| | Glutamine | 1 | 2017 | 103 | 0.030 |
Why?
| | Water | 1 | 2000 | 460 | 0.030 |
Why?
| | Hydrazines | 1 | 1996 | 35 | 0.030 |
Why?
| | Endoribonucleases | 1 | 2017 | 81 | 0.030 |
Why?
| | Aged | 6 | 2025 | 23961 | 0.030 |
Why?
| | New South Wales | 2 | 1993 | 19 | 0.030 |
Why?
| | Cell Membrane | 1 | 2000 | 738 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 340 | 0.030 |
Why?
| | Rats, Inbred WKY | 1 | 2015 | 36 | 0.030 |
Why?
| | Rats, Inbred SHR | 1 | 2015 | 45 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1996 | 375 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1477 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 346 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1996 | 119 | 0.030 |
Why?
| | Deoxyribonucleotides | 1 | 1995 | 19 | 0.030 |
Why?
| | Pituitary Neoplasms | 1 | 2017 | 190 | 0.030 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1996 | 230 | 0.030 |
Why?
| | Response Elements | 1 | 2015 | 91 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2015 | 159 | 0.030 |
Why?
| | Hydrolysis | 1 | 1995 | 177 | 0.030 |
Why?
| | Culture Media | 1 | 1995 | 165 | 0.030 |
Why?
| | Craniocerebral Trauma | 1 | 1996 | 170 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1996 | 202 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2015 | 366 | 0.030 |
Why?
| | Organ Size | 1 | 2015 | 477 | 0.030 |
Why?
| | Adult | 8 | 2025 | 37929 | 0.030 |
Why?
| | Hepatitis B Core Antigens | 1 | 1993 | 3 | 0.030 |
Why?
| | Tissue Embedding | 1 | 1993 | 4 | 0.030 |
Why?
| | Hepatitis B Antibodies | 1 | 1993 | 11 | 0.030 |
Why?
| | Killer Cells, Lymphokine-Activated | 1 | 1993 | 12 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2001 | 940 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2025 | 15657 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 1996 | 266 | 0.030 |
Why?
| | Glucose Solution, Hypertonic | 1 | 1993 | 1 | 0.030 |
Why?
| | Urban Health | 1 | 1993 | 92 | 0.030 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1993 | 98 | 0.030 |
Why?
| | Triglycerides | 1 | 2015 | 524 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 1993 | 114 | 0.030 |
Why?
| | Seroepidemiologic Studies | 1 | 1993 | 165 | 0.030 |
Why?
| | Metabolic Clearance Rate | 1 | 1993 | 115 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 1996 | 307 | 0.030 |
Why?
| | Cell Division | 3 | 2001 | 794 | 0.020 |
Why?
| | Methylococcaceae | 1 | 1992 | 2 | 0.020 |
Why?
| | Aged, 80 and over | 4 | 2001 | 7635 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1995 | 597 | 0.020 |
Why?
| | Cytokines | 3 | 1996 | 2085 | 0.020 |
Why?
| | Autoradiography | 1 | 1991 | 78 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 1991 | 26 | 0.020 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1991 | 28 | 0.020 |
Why?
| | Electrochemistry | 1 | 1991 | 78 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2015 | 635 | 0.020 |
Why?
| | Prospective Studies | 2 | 2021 | 7604 | 0.020 |
Why?
| | Antigens, CD | 1 | 1993 | 521 | 0.020 |
Why?
| | Urease | 2 | 2000 | 11 | 0.020 |
Why?
| | Interleukin-4 | 2 | 2001 | 216 | 0.020 |
Why?
| | Interleukin-8 | 2 | 2001 | 268 | 0.020 |
Why?
| | Chloride Channels | 2 | 2001 | 35 | 0.020 |
Why?
| | Immunoglobulin A | 2 | 2001 | 211 | 0.020 |
Why?
| | Heroin Dependence | 1 | 1989 | 33 | 0.020 |
Why?
| | Case-Control Studies | 1 | 1996 | 3556 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 13209 | 0.020 |
Why?
| | Lymphocyte Count | 2 | 1998 | 148 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 1993 | 641 | 0.020 |
Why?
| | Methadone | 1 | 1989 | 101 | 0.020 |
Why?
| | Phosphorylation | 1 | 1992 | 1759 | 0.020 |
Why?
| | Computer Simulation | 1 | 2011 | 978 | 0.020 |
Why?
| | Prevalence | 1 | 1993 | 2734 | 0.020 |
Why?
| | Immunoglobulin G | 2 | 2001 | 893 | 0.020 |
Why?
| | Ambulatory Care | 1 | 1989 | 546 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1995 | 4295 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 1989 | 527 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2001 | 4193 | 0.010 |
Why?
| | Immunohistochemistry | 2 | 1998 | 1738 | 0.010 |
Why?
| | Blood Glucose | 1 | 1993 | 2186 | 0.010 |
Why?
| | Xanthine | 1 | 2001 | 7 | 0.010 |
Why?
| | Thymidine | 1 | 2001 | 60 | 0.010 |
Why?
| | Colforsin | 1 | 2001 | 53 | 0.010 |
Why?
| | Mannitol | 1 | 2001 | 38 | 0.010 |
Why?
| | Receptors, Interleukin-2 | 1 | 2001 | 66 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1996 | 10811 | 0.010 |
Why?
| | RNA Probes | 1 | 2001 | 13 | 0.010 |
Why?
| | Hepatitis Delta Virus | 1 | 2001 | 7 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2001 | 14 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2001 | 234 | 0.010 |
Why?
| | Dyspepsia | 1 | 2000 | 10 | 0.010 |
Why?
| | Blood Cells | 1 | 2000 | 40 | 0.010 |
Why?
| | Gastric Mucosa | 1 | 2000 | 55 | 0.010 |
Why?
| | Intestine, Small | 1 | 2001 | 156 | 0.010 |
Why?
| | Antibodies, Bacterial | 1 | 2001 | 146 | 0.010 |
Why?
| | CD4 Antigens | 1 | 2000 | 141 | 0.010 |
Why?
| | Mitogens | 1 | 1999 | 61 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 976 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2001 | 1316 | 0.010 |
Why?
| | Endotoxins | 1 | 1999 | 220 | 0.010 |
Why?
| | Lymphocyte Subsets | 1 | 1998 | 87 | 0.010 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2001 | 329 | 0.010 |
Why?
| | Disaccharidases | 1 | 1996 | 1 | 0.010 |
Why?
| | Ion Transport | 1 | 1996 | 60 | 0.010 |
Why?
| | Mucins | 1 | 1996 | 73 | 0.010 |
Why?
| | Immunoblotting | 1 | 1996 | 308 | 0.010 |
Why?
| | Keratins | 1 | 1996 | 173 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 417 | 0.010 |
Why?
| | Epithelium | 1 | 1996 | 313 | 0.010 |
Why?
| | Cycloheximide | 1 | 1994 | 55 | 0.010 |
Why?
| | DNA Probes | 1 | 1994 | 60 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1793 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 152 | 0.010 |
Why?
| | CD56 Antigen | 1 | 1993 | 35 | 0.010 |
Why?
| | Child | 1 | 1993 | 21935 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2000 | 1430 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1993 | 75 | 0.010 |
Why?
| | DNA Primers | 1 | 1994 | 515 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 1994 | 181 | 0.010 |
Why?
| | CD3 Complex | 1 | 1993 | 106 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1993 | 219 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1993 | 224 | 0.010 |
Why?
| | Interleukins | 1 | 1994 | 250 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1994 | 1092 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1998 | 900 | 0.010 |
Why?
| | Apoptosis | 1 | 1999 | 2553 | 0.010 |
Why?
| | Epithelial Cells | 1 | 1996 | 1096 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1989 | 180 | 0.000 |
Why?
| | Fibroblasts | 1 | 1994 | 996 | 0.000 |
Why?
| | Intestinal Mucosa | 1 | 1993 | 623 | 0.000 |
Why?
| | Pregnancy | 1 | 1989 | 6763 | 0.000 |
Why?
|
|
Batey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|